MedTrace Logo

Tissue Factor Expression in Stage C Heart Failure

NCT00935740 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2009-07-09

No results posted yet for this study

Summary

Monocyte tissue factor (TF) was characterized in Class C heart failure (HF) vs. 25 age-matched volunteers. TF was 2.9 fold higher (p \< 0.001) in HF patients vs. controls. HF patients showed increased clinical events (RR=1.29, p=0.04) when comparing procoagulant activity above/below median. HF is associated with increased TF expression.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Mark A Munger, Pharm.D. · University of Utah

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1996-12-31
Primary Completion
2009-01-31
Completion
2009-01-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00935740 on ClinicalTrials.gov